What's Happening Archives - Page 2 of 8 - Sanford Burnham Prebys
Institute News

Will you be part of the largest-ever clinical research study?

Authorjmoore
Date

March 23, 2016

It’s called the Precision Medicine Initiative (PMI) Cohort Program, and it was just announced in February by President Obama. If you join the cohort (group of subjects tracked over a long period of time), you can help researchers improve precision medicine, in which doctors select the treatments and preventive strategies that will work best for each patient. This program is just one component of the larger Precision Medicine Initiative announced during last year’s State of the Union address.

What’s the goal? According to NIH Director Francis Collins, the cohort program “seeks to extend precision medicine to all diseases by building a national research cohort of one million or more U.S. participants,” all enrolled by 2019.

Why recruit so many people? Since the program is intended to benefit people affected by many diseases and conditions, it must include large, representative samples of people with each type. Large samples increase the likelihood that studies using these data will find new associations and interactions among genes, environmental factors, and disease risk.

What will participants do? Volunteers will share their health records, complete surveys on lifestyle and environmental exposures, undergo a physical, and provide a biological sample (e.g. blood) for genetic testing.

How will people benefit? Participants will be considered partners in research—they’ll have access to their genetic data and, where possible, how their genes, surroundings, and habits affect their health. They’ll also have a say in how the research is conducted and what questions it should address.

Who’s running it? The NIH is overseeing the whole program, but it will be directly run from multiple institutions (which are currently being selected). The pilot phase will be led by Vanderbilt University and Verily (formerly Google Life Sciences).

What’s the cost? $130 million has been allotted in this fiscal year, but more money will be needed to keep the program going.

Should I be excited about it? Maybe. Some leaders in the health field have criticized the program for throwing money at the latest big thing instead of more low-tech problems like unequal access to healthcare, but such a huge data resource is bound to lead to answers to many important questions. 

What are the challenges for the PMI?

  • Scale—The program will generate one of the largest clinical databases yet, and it’s not clear how difficult it will be to make systems that can store and analyze it.
  • Privacy—Data will be anonymized, but keeping the health information of a million people in one place might represent a target for hackers sophisticated enough to figure out participants’ identities.
  • Interoperability—Health record systems are notoriously incompatible with one another. Though the PMI also has provisions to correct this, it likely won’t be a quick fix.

How can I sign up? Enrollment has not yet begun, but the NIH will announce when the public can get involved. So stay tuned…

 

Institute News

SBP scientists join race for a cure

Authordrobison
Date

March 17, 2016

Andrew Carley, PhD, has a personal motivation for finding a cure for diabetes. As one of the 29 million Americans with diabetes, he became a biomedical researcher to better understand the causes of disease.

For Julio Ayala, PhD, a passion for medical research was sparked by his grandmother, a type 1 diabetic, who at age 86 has successfully managed the disease most of her life.

Julio Ayala, PhD
Julio Ayala, PhD

Siobhan Malany, PhD, is an avid cyclist who believes so strongly in team efforts that she has enlisted robots to join her research team searching for new drugs to fight disease.

On Sunday, March 13, 2016, these Sanford Burnham Prebys scientists took their interest in biomedical research to the roadways of Central Florida as they joined 1,100 participants in the 2016 Tour de Cure at Lake Nona bicycle ride for diabetes. The twelve-member SBP team collectively pedaled more than 400 miles and raised $9,000 to fight the disease. Participants began the 25, 63, and 100-mile courses in Lake Nona Medical City near SBP and the Center for Metabolic Origins of Disease, the site where researchers study diabetes in hopes of identifying new, more effective therapies.

“It was a fun way to give back and do what I love to do.  Cycling has been my commute, my sport and my escape —now it’s a way to contribute,” said Malany, who completed the 100-mile course in five hours. She enjoyed the camaraderie and credited the group with a bit of competitive motivation. “I kept a 21.5 mile per hour pace, which was not something I would have accomplished had I been cycling alone. It was fast and fun being in a pack because you conserve energy by drafting,” added Malany.

Siobhan Malany, PhD
Siobhan Malany, PhD

Since moving to Lake Nona in December from Chicago, Carley has gotten back into cycling and now bikes to the Institute in Medical City each day. He completed a Century ride to mark the 20th anniversary of the Tour de Cure in 2011 in Chicago and decided to mark the 25th anniversary of the event with a 25 mile ride. “I selected the 25 mile course because it was the maximum length of time my 3-year old daughter would remain content in her bike stroller watching a Toy Story movie. She weighs only 32 pounds and the course was relatively flat so we were able to complete the ride in two hours despite frequent stops,” said Carley.

Tour-de-cure

Team captain Ayala participated in various ADA and JDRF fund raising events while at Vanderbilt University. “While riding my bike to work a few years ago, I saw the first Tour de Cure in Lake Nona and knew that I wanted to participate. We study diseases of metabolism at the Medical City site and a number of faculty, including me, receive ADA-funded grants, so I wanted to get involved,” said Ayala.

Ayala credits the team’s spirit with providing extra motivation to push through the extreme winds encountered on the course. It’s with similar determination that they approach their daily race for the cure in their research labs.

Institute News

SBP helps students “worm” up to science at STEM Expo

Authorsgammon
Date

March 7, 2016

On Saturday, March 5, a keen group of SBP volunteers hauled wagons of lab coats, mutant worms and magnifying glasses to give the next generation of scientists—mainly kids in grades K-8—an opportunity to see first-hand how tiny worms named C. elegans are used to understand the aging process.

More

Institute News

SBP’s Michael Jackson and Alzheimer’s San Diego CEO Mary Ball talk Alzheimer’s

Authorkcusato
Date

December 28, 2015

$2 billion dollars for 10 years.  That’s what democratic presidential candidate Hillary Clinton has proposed infusing into research to end Alzheimer’s by 2025.

With more than 5 million people living with Alzheimer’s or another form of dementia, including 60,000 in San Diego, the additional funds would propel many important research projects forward.

SBP’s Senior Vice President of Drug Discovery and Development, Michael Jackson, PhD, and Alzheimer’s San Diego CEO Mary Ball appeared on the KUSI news in San Diego on December 22nd to talk about the Clinton proposal and the status of Alzheimer’s research here in San Diego.

Watch the video here

Institute News

SBP’s Sheila Collins’ diabetes research featured in Orlando Sentinel

Authorsgammon
Date

December 21, 2015

“Obesity has reached epidemic proportions in the United States. Over 60 percent of the population can be classified as overweight or obese, placing them at risk for a large number of chronic diseases, including insulin resistance, cardiovascular disease, and type 2 diabetes,” says Sheila Collins, PhD, professor at SBP’s Lake Nona campus.

“There is a critical need for novel approaches to treating obesity—in particular, agents acting to increase energy expenditure would be valuable.”

Read the article in the Orlando Sentinel by Naseem S. Miller about how Collins is studying hormones produced by the heart to prevent obesity and possibly the myriad of disorders that come with it.

Institute News

You’re invited to a psoriasis research update and reception

Authormigartua
Date

December 15, 2015

Come join us at Sanford Burnham Prebys Medical Discovery Institute (SBP) to learn about the latest research in psoriasis and psoriatic arthritis taking place in your community. The Psoriasis Research Update and Reception is jointly sponsored by SBP and the National Psoriasis Foundation. The event will take place on:

Tuesday, February 2, 2016 6:00 – 8:00 p.m. Sanford Burnham Prebys Medical Discovery Institute Building 12 Auditorium 10905 Road to the Cure San Diego, CA 92121

Take a tour of the SBP Psoriasis Research Lab and come to the reception where we will provide hors d’oeuvres and beverages.

 

Our guest speakers will include:

  • Carl Ware, PhD, Director of SBP’s Infectious and Inflammatory Diseases Center
  • John Sedy, PhD, Research Assistant Professor
  • Randy Beranek, President and CEO of the National Psoriasis Foundation
  • Erik Gilbertson, MD, Division Head of Dermatology at Scripps Clinic

RSVP to hbuthmann@sbpdiscovery.org by January 29, 2015 to reserve your spot.

 

We look forward to seeing you there!

Institute News

Introducing our new Communications Manager, Kristen Cusato

AuthorGuest Blogger
Date

December 15, 2015

Hello everyone!

I am so pleased to be joining the Sanford Burnham Prebys (SBP) team.

I have been in television news at stations all over the country for more than 20 years, most recently at KUSI TV in San Diego. Finding and telling stories is my specialty, and I’d love to hear what you think is unique about SBP and the people who work here. One of my passions is educating about Alzheimer’s disease and other forms of dementia, in that my Mother passed away at the age of 65 from the mind-robbing disease. I am happy to be working at a place where medical discoveries of all kinds are improving and saving lives.

I believe in what happens here, and will do everything I can to make sure SBP, the scientists who do research and the people who make this place run, get the recognition in the media and elsewhere they so richly deserve.